Clinical Trials Directory

Trials / Completed

CompletedNCT00907101

Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes

Evaluation of the Effectiveness of Epiduo® Gel (Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel) in Reducing Antibiotic Sensitive and Resistant Strains of P Acnes

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness of Epiduo® Gel in reducing antibiotic sensitive and resistant strains of P acnes in vivo.

Conditions

Interventions

TypeNameDescription
DRUGAdapalene 0.1%/Benzoyl Peroxide 2.5% Gel (Epiduo® Gel)Apply once daily

Timeline

Start date
2009-06-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2009-05-22
Last updated
2022-08-01
Results posted
2016-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00907101. Inclusion in this directory is not an endorsement.